Duodenal Ulcer Promoting Gene of Helicobacter Pylori

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2005 Apr 13

PMID 15825067

Citations 125

Authors

Hong Lu

Ping-I Hsu

David Y Graham

Yoshio Yamaoka

Affiliations

Soon will be listed here.

Abstract

Background & Aims: Identification of a disease-specific H pylori virulence factors predictive of the outcome of infection remains unachieved.

Methods: We used the polymerase chain reaction and Southern blot to compare the presence of 14 vir homologue genes with clinical presentation of H pylori infection, mucosal histology, and mucosal interleukin (IL)-8 levels.

Results: We examined 500 H pylori strains from East Asia and South America, including 120 with gastritis, 140 with duodenal ulcer (DU), 110 with gastric ulcer (GU), and 130 with gastric cancer. Only 1 gene that encompassed both jhp0917 and jhp0918 called dupA (duodenal ulcer promoting gene) was associated with a specific clinical outcome. dupA was present in 42% of DU vs. 21% of gastritis (adjusted odds ratio [OR] = 3.1, 95% confidence interval [CI]: 1.7-5.7). Its presence was also associated with more intense antral neutrophil infiltration and IL-8 levels and was a marker for protection against gastric atrophy, intestinal metaplasia, and gastric cancer (OR for gastric cancer = 0.42, 95% CI: 0.2-0.9 compared with gastritis). In vitro studies in gastric epithelial cells using dupA -deleted and -complemented mutants showed that the dupA plays roles in IL-8 production, in activation of transcription factors responsible for IL-8 promoter activity, and in increased survivability at low pH.

Conclusions: dupA is a novel marker associated with an increased risk for DU and reduced risk for gastric atrophy and cancer. Its association with DU-promoting and -protective effects against atrophy/cancer was evident in both Asian and Western countries.

Citing Articles

Study of the relationships among known virulence genes, coccoid transformation and cytotoxicity of in different clinical diseases.

Xiao Y, Zhang B, Zhang H, Zhang Z, Meng F, Zhao X Virulence. 2024; 15(1):2418407.

PMID: 39420787 PMC: 11497995. DOI: 10.1080/21505594.2024.2418407.

The immunopathogenesis of -induced gastric cancer: a narrative review.

Shirani M, Shariati S, Bazdar M, Sojoudi Ghamnak F, Moradi M, Shams Khozani R Front Microbiol. 2024; 15:1395403.

PMID: 39035439 PMC: 11258019. DOI: 10.3389/fmicb.2024.1395403.

Implications of lncRNAs in -associated gastrointestinal cancers: underlying mechanisms and future perspectives.

Zhang L, Yu F, Zhang Y, Li P Front Cell Infect Microbiol. 2024; 14:1392129.

PMID: 39035354 PMC: 11257847. DOI: 10.3389/fcimb.2024.1392129.

East Asian type CagA hijacks more SHIP2 by its EPIYA-D motif to potentiate the oncogenicity.

Ji X, Wu Q, Cao X, Liu S, Zhang J, Chen S Virulence. 2024; 15(1):2375549.

PMID: 38982595 PMC: 11238919. DOI: 10.1080/21505594.2024.2375549.

Outer Membrane Proteins and Virulence Factors: Potential Targets for Novel Therapies and Vaccines.

Sedarat Z, Taylor-Robinson A Pathogens. 2024; 13(5).

PMID: 38787244 PMC: 11124246. DOI: 10.3390/pathogens13050392.

References

Dougherty B, Hill C, Weidman J, Richardson D, Venter J, Ross R . Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol Microbiol. 1998; 29(4):1029-38. DOI: 10.1046/j.1365-2958.1998.00988.x. View

Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham D . Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998; 3(4):241-53. DOI: 10.1046/j.1523-5378.1998.08056.x. View

Alm R, Ling L, Moir D, King B, Brown E, Doig P . Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999; 397(6715):176-80. DOI: 10.1038/16495. View

Covacci A, Telford J, Del Giudice G, Parsonnet J, Rappuoli R . Helicobacter pylori virulence and genetic geography. Science. 1999; 284(5418):1328-33. DOI: 10.1126/science.284.5418.1328. View

Schroder G, Krause S, Zechner E, Traxler B, Yeo H, Lurz R . TraG-like proteins of DNA transfer systems and of the Helicobacter pylori type IV secretion system: inner membrane gate for exported substrates?. J Bacteriol. 2002; 184(10):2767-79. PMC: 135038. DOI: 10.1128/JB.184.10.2767-2779.2002. View

Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Boren T . Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol. 2002; 40(6):2244-6. PMC: 130665. DOI: 10.1128/JCM.40.6.2244-2246.2002. View

Yamaoka Y, Kikuchi S, El-Zimaity H, Gutierrez O, Osato M, Graham D . Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002; 123(2):414-24. DOI: 10.1053/gast.2002.34781. View

Hsu P, Hwang I, Cittelly D, Lai K, El-Zimaity H, Gutierrez O . Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002; 97(9):2231-8. DOI: 10.1111/j.1572-0241.2002.05977.x. View

Graham D, Opekun A, Yamaoka Y, Osato M, El-Zimaity H . Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003; 17(2):193-200. DOI: 10.1046/j.1365-2036.2003.01400.x. View

10.

Santos A, Queiroz D, Menard A, Marais A, Rocha G, Oliveira C . New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol. 2003; 41(4):1651-5. PMC: 153914. DOI: 10.1128/JCM.41.4.1651-1655.2003. View

11.

Kersulyte D, Velapatino B, Mukhopadhyay A, Cahuayme L, Bussalleu A, Combe J . Cluster of type IV secretion genes in Helicobacter pylori's plasticity zone. J Bacteriol. 2003; 185(13):3764-72. PMC: 161572. DOI: 10.1128/JB.185.13.3764-3772.2003. View

12.

Buhrdorf R, Forster C, Haas R, Fischer W . Topological analysis of a putative virB8 homologue essential for the cag type IV secretion system in Helicobacter pylori. Int J Med Microbiol. 2003; 293(2-3):213-7. DOI: 10.1078/1438-4221-00260. View

13.

Yu Y, Zhang Y, Zhang W, Shen L, Hertzog P, Wilson T . Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol. 2003; 9(10):2154-9. PMC: 4656453. DOI: 10.3748/wjg.v9.i10.2154. View

14.

Yamaoka Y, Kudo T, Lu H, Casola A, Brasier A, Graham D . Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004; 126(4):1030-43. DOI: 10.1053/j.gastro.2003.12.048. View

15.

Yakovleva T, Kolesnikova L, Vukojevic V, Gileva I, Tan-No K, Austen M . YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun. 2004; 318(2):615-24. DOI: 10.1016/j.bbrc.2004.04.065. View

16.

de Jonge R, Kuipers E, Langeveld S, Loffeld R, Stoof J, Van Vliet A . The Helicobacter pylori plasticity region locus jhp0947-jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol. 2004; 41(2):161-7. DOI: 10.1016/j.femsim.2004.03.003. View

17.

Carroll I, Khan A, Ahmed N . Revisiting the pestilence of Helicobacter pylori: insights into geographical genomics and pathogen evolution. Infect Genet Evol. 2004; 4(2):81-90. DOI: 10.1016/j.meegid.2004.01.006. View

18.

Sui G, Affar E, Shi Y, Brignone C, Wall N, Yin P . Yin Yang 1 is a negative regulator of p53. Cell. 2004; 117(7):859-72. DOI: 10.1016/j.cell.2004.06.004. View

19.

Gronroos E, Terentiev A, Punga T, Ericsson J . YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004; 101(33):12165-70. PMC: 514451. DOI: 10.1073/pnas.0402283101. View

20.

Lu H, Graham D, Yamaoka Y . The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004; 49(9):1551-5. DOI: 10.1023/b:ddas.0000042263.18541.ec. View